BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 44 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,960,000 | +1.2% | 25,280,000 | -16.5% | 0.51% | +22.6% |
| Q2 2023 | $18,739,598 | -36.1% | 30,280,000 | -33.1% | 0.42% | -39.5% |
| Q1 2023 | $29,312,082 | +88.1% | 45,280,000 | +10.9% | 0.69% | +120.5% |
| Q4 2022 | $15,586,610 | -13.9% | 40,816,000 | 0.0% | 0.31% | -1.0% |
| Q3 2022 | $18,110,000 | +45.8% | 40,816,000 | +39.2% | 0.32% | +41.3% |
| Q2 2022 | $12,421,000 | -19.7% | 29,316,000 | -7.9% | 0.22% | -20.4% |
| Q1 2022 | $15,472,000 | – | 31,816,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 43,287,000 | $27,670,133 | 4.63% |
| Affinity Asset Advisors, LLC | 11,000,000 | $7,120,872 | 2.35% |
| INHERENT GROUP, LP | 31,250,000 | $20,000,750 | 2.27% |
| Context Capital Management, LLC | 26,583 | $17,209 | 1.44% |
| BRAIDWELL LP | 42,294,000 | $27,379,090 | 0.90% |
| DeepCurrents Investment Group LLC | 35,355,000 | $22,459,155 | 0.88% |
| ARISTEIA CAPITAL, L.L.C. | 45,280,000 | $29,312,082 | 0.69% |
| Aequim Alternative Investments LP | 31,000,000 | $20,067,912 | 0.64% |
| Saltoro Capital, LP | 1,600,000 | $979,200 | 0.61% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,000,000 | $3,130,846 | 0.46% |